Related Experiment Video

Updated: Jun 23, 2026

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
12:55

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells

Published on: October 10, 2017

Characteristics and consequences of muscarinic receptor activation by tau protein

Alberto Gómez-Ramos1, Miguel Díaz-Hernández, Alicia Rubio

  • 1Centro de Biología Molecular "Severo Ochoa" (CSIC-UAM), 28049 Madrid, Spain.

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|May 9, 2009
PubMed

Insights

Tau protein, released during neuronal death, is toxic to nearby cells by activating muscarinic receptors. Unlike acetylcholine, tau protein exhibits higher affinity and does not cause receptor desensitization, contributing to neurodegeneration in tauopathies.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cell Biology

Background:

  • Neuronal death releases tau protein, implicated in neurotoxicity via muscarinic M1/M3 receptor activation.
  • The specific mechanisms underlying tau-induced neurotoxicity compared to native agonists like acetylcholine (ACh) remain unclear.

Purpose of the Study:

  • To investigate and compare the distinct interactions and effects of tau protein and acetylcholine (ACh) on muscarinic receptors.
  • To elucidate the molecular basis for tau protein's specific neurotoxic potential in tauopathies.

Main Methods:

  • Comparative analysis of muscarinic receptor activation by tau protein and acetylcholine (ACh).
  • Assessment of receptor affinity, desensitization patterns, and protein stability in the extracellular environment.

Main Results:

  • Tau protein demonstrated a significantly higher affinity for muscarinic receptors compared to ACh (approximately one order of magnitude greater).
  • Repeated ACh stimulation led to muscarinic receptor desensitization, whereas tau protein stimulation did not induce this effect.
  • Tau protein exhibited remarkable stability in the extracellular milieu.

Conclusions:

  • Tau protein's enhanced affinity and resistance to desensitization at muscarinic receptors contribute to its neurotoxic effects.
  • These findings offer critical insights into tau-mediated neurotoxicity and its role in the progression of tauopathies.
  • Understanding these interactions is vital for developing therapeutic strategies targeting neurodegenerative diseases.

More Related Videos

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein09:22

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia07:18

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Published on: November 9, 2018

Related Concept Videos

Cholinergic Receptors: Muscarinic01:25

Cholinergic Receptors: Muscarinic

The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine. 
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
Direct-Acting Cholinergic Agonists: Pharmacological Actions00:59

Direct-Acting Cholinergic Agonists: Pharmacological Actions

Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Cholinergic Antagonists: Pharmacological Actions01:28

Cholinergic Antagonists: Pharmacological Actions

Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...